Channel:  Aligning Science Across Parkinson's (ASAP)

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

346 Articles

A staged screening protocol identifies people with biomarkers related to neuronal alpha-synuclein disease
Brown, E. G., Chahine, L. M., Siderowf, A., Gochanour, C., Kurth, R., Marshall, M. J., Caspell-Garcia, C., Brumm, M. C., Coffey, C. S., Stanley, C. E., Korell, M., McMahon, B., Kuhl, M., Fabrizio, K., Heathers, L., Foroud, T. M., Concha-Marambio, L., Soto, C., Chowdhury, S., Simuni, T., Marek, K., Tanner, C. M., the Parkinson's Progression Markers Initiative
10.1101/2024.06.03.24308229 — Posted: 2024-06-04
Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's disease
Sodders, M. J., Avila-Pacheco, J., Okorie, E. C., Shen, M., Kumari, N., Marathi, A., Lakhani, M., Bullock, K., Pierce, K., Dennis, C., Jeanfavre, S., Sarkar, S., Scherzer, C. R., Clish, C., Olsen, A. L.
10.1101/2024.05.15.594309 — Posted: 2024-06-02
The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics
Evans, J. R., Gustavsson, E. K., Doykov, I., Murphy, D., Virdi, G., Lachica, J., Rontgen, A., Murtada, M. H., Pang, C. W., Macpherson, H., Wernick, A. I., Toomey, C. E., Athauda, D., Choi, M., Hardy, J., Wood, N. W., Vendruscolo, M., Mills, K., Heywood, W., Ryten, M., Gandhi, S.
10.1101/2024.05.30.596437 — Posted: 2024-05-31
Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease
Payami, H., Sampson, T. R., Murchison, C. F., Wallen, Z. D.
10.1101/2024.04.03.24305273 — Posted: 2024-05-30
3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale X-ray phase-contrast tomography
Reichmann, J., Franz, J., Eckermann, M., Schulz, K., Mollenhauer, B., Stadelmann, C., Salditt, T.
10.1101/2024.03.26.24304193 — Posted: 2024-05-28
Movement-related increases in subthalamic activity optimize locomotion
Callahan, J. W., Morales, J. C., Atherton, J. F., Wang, D., Kostic, S., Bevan, M. D.
10.1101/2023.12.07.570617 — Posted: 2024-05-28
Tagless LysoIP method for molecular profiling of lysosomal content in clinical samples
Saarela, D., Lis, P., Gomes, S., Nirujogi, R. S., Dong, W., Rawat, E., Glendinning, S., Zeneviciute, K., Bagnoli, E., Fasimoye, R., Lin, C., Nyame, K., Boros, F. A., Zunke, F., Lamoliatte, F., Elshani, S., Jaconnelli, M., Jans, J. J. M., Huisman, M. A., Posern, C., Westermann, L. M., Schulz, A., van Hasselt, P. M., Alessi, D. R., Abu-Remaileh, M., Sammler, E.
10.1101/2024.05.17.594681 — Posted: 2024-05-27
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes
Stedehouder, J., Roberts, B. M., Raina, S., Bossi, S., Liu, A. K. L., Doig, N. M., McGerty, K., Magill, P. J., Parkkinen, L., Cragg, S. J.
10.1101/2024.05.15.594341 — Posted: 2024-05-15
Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein
Gcwensa, N. Z., Russell, D. L., Long, K. Y., Brzozowski, C. F., Liu, X., Gamble, K. L., Cowell, R. M., Volpicelli-Daley, L.
10.1101/2024.05.15.594419 — Posted: 2024-05-15
Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
Rademacher, K. L., Doric, Z., Haddad, D., Mamaligas, A., Liao, S.-C., Creed, R., Kano, K., Chatterton, Z., Fu, Y., Garcia, J. H., Vance, V., Sei, Y., Kreitzer, A., Halliday, G., Nelson, A., Margolis, E., Nakamura, K. L.
10.1101/2024.04.05.588321 — Posted: 2024-05-13

RSS  Channel RSS